Context: Fetuses exposed to the high thyroid hormone (TH) levels of mothers with resistance to thyroid hormone beta (RTH-b), due to mutations in the THRB gene, have low birth weight and suppressed TSH.
metabolic consequences or is limited to some organ systems (4) . In this sense, the study of women with RTH-b carrying wild-type (WT, without THRB gene mutations) fetuses provides a unique opportunity to evaluate the direct effect of maternal TH excess on the fetus. In previous studies in an extended Azorean family harboring the THRB gene mutation R243Q, we have shown that affected mothers miscarry a greater proportion of WT embryos and that infants born to such mothers have suppressed neonatal thyrotropin (TSH) and low birth weight (5) . Taken together, these findings indicate that WT fetuses exposed to high maternal TH levels during pregnancy develop hyperthyroid features. In neonates born with fetal hyperthyroidism, the resulting central hypothyroidism is transient (6, 7) . In contrast, normal mice born to dams with high TH levels due to lack of TH receptor beta (Thrb) gene develop partial central resistance to TH despite the presence of a normal TH receptor beta (8) . These data from adult animals suggest that exposure of human embryos to high TH levels may not only have transient effect on the newborn but possibly also permanent effects on the progeny.
In the current study, we examined WT adults without THRB gene mutations from the same Azorean family born to mothers with THRB gene mutations. The control group consisted also of WT adults but born to WT euthyroid mothers and conceived by fathers with THRB gene mutations. To gain information regarding the mechanism whereby intrauterine exposure to high TH levels affects the adult progeny, we used genetically manipulated mice with disruption of both alleles of Thrb gene, which mimics the phenotype of humans harboring a heterozygous THRB gene mutation. They were mated to carry normal progeny in dams with RTH-b as well as in normal dams mated to male mice with RTH-b (9, 10). Only humans and mice born to mothers with RTH-b having high TH levels developed reduced central sensitivity to TH that was persistent during adulthood.
Materials and Methods

Humans and in vivo study design
The human study groups consisted of WT (without THRB gene mutations) adults belonging to the same extended Azorean family born to mothers with RTH-b due the mutation R243Q in one allele of the THRB gene. Control subjects were WT adults born to WT mothers but to fathers with RTH-b due the same THRB gene mutation. Each group had three female subjects and one male subject. The overall age range was 22 to 54 years.
Heterozygous individuals with missense mutations in the hormone-binding domain of the THRB gene, such as that harbored in this family, produce the phenotype of RTH-b due to interference of the mutant receptor with the normal one. This phenomenon is known as the "dominant negative effect" (11) . In contrast, deletion of a WT THRB gene in one allele has no phenotype because a single WT THRB gene is sufficient for normal function, and therefore the absence of a mutant allele does not exert a dominant negative effect. However, deletion of both THRB alleles produces the RTH-b phenotype (12) . Individuals with RTH-b have high TH levels with a nonsuppressed TSH. None of the subjects studied had autoimmune thyroid disease as documented clinically and by the absence of thyroid autoantibodies.
Each individual was given intravenously 200 mg thyrotropinreleasing hormone (TRH) before and again 3 months later after 3 days treatment with 25 mg of triiodothyronine (liothyronine, L-T 3 ) taken orally twice daily. Serum was collected at 215, 0, 15, 30, 45, 60, 90, 120, and 180 minutes relative to the TRH administration for measurement of TSH and prolactin (PRL). The following additional substances were measured in the samples obtained at 215 minutes: total T 4 , T 3 , and reverse T 3 (rT 3 ), free T 4 index (FT 4 I), thyroglobulin, sex hormone-binding globulin, ferritin, cholesterol, and creatinine kinase. A graphic depiction of the protocol is provided in Fig. 1 (c) and 1(d).
The tests described previously were obtained at baseline from a larger group of adult subjects belonging to the same extended family. The number of individuals in each group is provided in the tables. The study was approved by the Institutional Review Boards of Hospital Divino Espírito Santo and The University of Chicago.
Mice and in vivo study design
The TH receptor beta knockout mouse (Thrb 2/2 ) was produced as described (13) , and mice were maintained in the C57BL/6 background. As in humans lacking one allele of the THRB gene (12) , heterozygous Thrb +/2 mice were indistinguishable in all respects from the WT Thrb +/+ mice ( Table 1) . Thrb 2/2 mice were chosen for the comparative studies because the magnitudes of serum T 4 , FT 4 I, and T 3 concentrations were comparable to those of humans heterozygous for the THRB R243Q when expressed as percent difference from the respective WT humans and Thrb +/2 mice ( Table 1) .
Mating strategies were as described in detail (8) . Briefly, female mice with RTH-b (Thrb ). The difference between these two mating strategies is that the progeny without RTH-b born to dams with RTH-b were exposed to high levels of TH during gestation, whereas in the reciprocal crossing the progeny were not exposed to hyperiodothyroninemic intrauterine environment. Mouse DNA extraction and genotyping were performed as previously described (10) . Thrb +/2 adult male progeny (60 to 80 days old) were used in the study because half of female mice without RTH-b have serum TSH values below the limit of the assay sensitivity (14) . Mice were given daily intraperitoneal injections of a low dose (0.2 mg) of L-T 3 /100 g body weight daily for four consecutive days. About 18 hours after the last injection, blood was obtained before and 15 minutes after intraperitoneal injection of 0.280 mg TRH. Serum was separated and frozen before determination of TSH concentration in both samples. Baseline measurements of total T 4 , T 3 , and rT 3 were obtained in all animals.
Groups of untreated and L-T 3 -treated mice were dissected, and the anterior pituitary glands, hypothalami, and cerebral cortices were collected. The number of animals used in each group is provided in the tables or legends to figures. Animal experiments were performed at The University of Chicago and at the University of Duisburg-Essen according to protocols approved by the respective Institutional Animal Care and Use Committees.
Hormones and RNA measurements
In human serum, total T 4 , and T 3 , TSH, and PRL were measured by chemiluminescence immunometric assays using the Elecsys Automated System (Roche Molecular Biochemicals GmbH and Hitachi, Ltd., Indianapolis, IN). Total rT 3 was measured by radioimmunoassay (Adaltis Italia S.p.A, Bologna, Italy), and thyroglobulin was measured by an in-house radioimmunoassay. FT 4 I, an estimate of the serum-free T 4 , is the product of serum T 4 concentration and the normalized resin T 4 uptake ratio.
In mouse serum, total T 4 , T 3 , and rT 3 as well as TSH were measured by radioimmunoassay using methods described in detail in the supplement to a publication by Ferrara et al. (15) . Before tissue harvesting, mice were perfused under anesthesia with heparinized phosphate-buffered saline through a needle placed in the left ventricle. The anterior pituitary, hypothalamus, and cerebral cortex were dissected, immediately frozen, and kept at 280°C until homogenized. RNA was extracted and used for measurement of specific mRNAs by quantitative real-time polymerase chain reaction as described in detail (15) . Amplification of the housekeeping gene ribonucleic acid polymerase 2 was used as internal control. Primer sequences are provided in Supplemental Table 1 .
Statistical analyses
All results are expressed as mean 6 standard error of the mean. Statistical analysis of multiple groups was by two-way analysis of variance with Fisher protected least significant difference test. Student t test was used when there were only two groups to compare. P , 0.05 was considered to be significant.
Results
Humans
Baseline thyroid function tests were not significantly different between subjects born to mothers with RTH-b compared with those born to fathers with RTH-b but WT mothers (Table 2) . Thyroid tests obtained from a larger group of subjects born to mothers with RTH-b showed a significant increase in rT 3 and a reduction in T 3 , which did not reach significance, compared with those born to fathers with RTH-b (Table 3) . However, the rT 3 / T 3 ratio was significantly higher (P , 0.03). After L-T 3 treatment, both groups had equally elevated serum T 3 and suppressed TSH (Table 2 ). Before L-T 3 treatment, mean peak serum TSH responses in individuals born to mothers with RTH-b, compared with those born to fathers with RTH-b, were 11.8 6 1.7 and 13.2 6 1.7 mU/L, respectively (P = 0.57). After L-T 3 treatment, the corresponding TSH values were 6.8 6 1.0 vs 1.6 6 0.5 (P , 0.003) [ Fig. 1(a) and 1(b) ; Table 2 ]. Differences were significant when expressed as the delta response relative to the basal values [ Fig. 2(a) ] and as the percentage of the basal value or the area under the curve (data not shown). There was no overlap between the post-L-T 3 treatment responses in individual subjects of both groups [ Fig. 1(a) ]. This demonstrates, despite the small number of subjects tested, a significantly reduced sensitivity to T 3 in adult subjects exposed during intrauterine life to elevated maternal TH levels. There were no differences in basal and stimulated serum PRL levels between the two groups before and after L-T 3 treatment (Table 2) . Furthermore, no significant differences between the two groups were found for markers of peripheral tissue action of TH, including serum sex hormone-binding globulin, ferritin, cholesterol, and creatinine kinase (data not shown).
Mice
Mice without RTH-b (Thrb +/2 ) born to dams with RTH-b (Thrb 2/2 ), but not those born to fathers with RTH-b, showed significantly reduced suppression of their serum TSH response to TRH after treatment with L-T 3 [ Fig. 2(b) ], replicating the human phenotype of reduced sensitivity to TH. Whereas differences in baseline serum T 3 and rT 3 concentration between the two groups did not reach statistical significance, the rT 3 /T 3 ratio did (Table 3 ). In addition, and contrary to humans, the mice without RTH-b born to dams with RTH-b had higher baseline serum TSH. To study the underlying mechanism, we examined the expression of genes involved in the hypothalamopituitary-thyroid axis. Results showed that TSH-b and D3 were increased in the pituitaries of mice born to dams with RTH-b [ Fig. 3(a) ]. This was observed in mice treated and in those not treated with L-T3 (Supplemental Fig. 1 ). The expression of other candidate genes was examined in anterior pituitaries and hypothalami. Other than the observed increases in anterior pituitary TSH-b and D3, expression of deiodinase 2 (D2) and TH receptor a1 (Thr-a1) was significantly reduced in hypothalami of mice born to dams with RTH-b [ Fig. 3(b) ]. No differences in D2 and D3 expression were found in the cerebral cortex [ Fig. 3(c) ].
Discussion
Our results show that exposure of human embryos to high maternal TH concentrations not only affects the newborn (5) but also reduces thyrotroph sensitivity to TH during adult life. Whether other tissues or only those involved in the central feedback regulation are affected remains to be determined. The lack of significant differences in peripheral tissue markers between the two groups of individuals at baseline and after L-T 3 treatment does not rule out more general effects because these markers require larger changes of TH to respond (4).
However, it appears certain that the effect was mediated by the high levels of TH derived from the mother acting on the fetus. Indeed, by virtue of the RTH-b, the mothers were not thyrotoxic and maintained high serum TH levels without abnormal thyroid-stimulating substances, whereas their WT newborns were thyrotoxic given their low birth weight and suppressed TSH (5). We used mice with RTH-b as models to probe into the mechanism because these mice maintained increased serum TH levels of similar magnitude as the humans with THRB R243Q under study ( Table 1) . As in humans, the effect of TH excess is confined to the progeny and limited to their intrauterine life. We were able to demonstrate that adult mice without RTH-b born to dams with RTHb had also reduced suppression of their TSH response to TRH after L-T 3 treatment. This did not occur in mice without RTH-b born to fathers with RTH-b whose mothers without RTH-b had normal serum TH levels.
Thus, they provided a good model to study the mechanism of this central resistance due to the availability of anterior pituitary and brain tissues.
As expected, TSH-b mRNA was increased in anterior pituitaries of mice born to dams with RTH-b, in agreement with their increased serum TSH in response to TRH. However, expression of the TRH receptor in the anterior pituitary and all three TH receptors was not altered [ Fig. 3(a) ]. Although, based on the altered response to TRH, we expected a defect at the level of the anterior pituitary rather than the hypothalamus, the latter tissue was also examined. Expression of TRH and TH receptor a2 was not significantly different in both groups of mice.
The other alteration in the anterior pituitary, besides the expected increase in TSH-b expression, was an increase in D3 mRNA. This enzyme, which inactivates both T 3 and T 4 , reduces the concentration of biologically active TH. Increased D3 expression and consequently increased T 3 degradation explain the reduced sensitivity of the anterior pituitary to administered L-T 3 in mice. Direct measurement of D3 enzymatic activity will require pooling of anterior pituitary tissue. However, the quantitative polymerase chain reaction, using 32 ng template RNA, was sufficiently robust (28 to 29 cycles), and, contrary to D2, there is a good correlation between D3 enzymatic activity and mRNA concentration in other tissues that have been examined (16, 17) . As shown in D3-deficient mice, this enzyme protects the fetus from the maternal TH excess (18) . D3 is imprinted in both mice and humans, and the imprinting is tissue-and age specific (19, 20) . Thus, D3 is a good candidate for the apparent epigenetic effect of intrauterine exposure to high TH concentrations. It is unknown whether the increase in D3 involves all anterior pituitary cells or only the thyrotrophs. If the effect is cell specific, it must be quite robust because the thyrotrophs represent a minority of the anterior pituitary cell population. A decrease in D2 activity, the enzyme that activates TH, was observed in the hypothalami of mice born to dams with RTH-b. This would decrease the generation of T 3 , further contributing to the hyposensitivity to TH. In fact, posttranscriptional regulation of D2 in the hypothalamus is less dependent on ubiquitination, and the observed decrease in D2 mRNA concentration may correlate with its enzyme activity (21) . However, reduction of hypothalamic D2 could not have a role in the reduced sensitivity to the administered L-T 3 . The small amount of anterior pituitary tissue and the low concentration of this hormone in the hypothalamus precluded direct measurement of T 3 tissue content. The observed slight (14%) decrease in the expression of the Thr-a1 in the hypothalamus is not expected to affect the TSH level as reported in Thr-a1 receptor-deficient mice and humans (22, 23) .
Several differences between results in humans and mice were observed. In progeny born to mothers with high TH, serum rT 3 was significantly increased in humans but not in mice, and although the mean decrease in serum T 3 was not significant in both species, the rT 3 /T 3 ratio was. Furthermore, mice born to mothers with RTHb showed a significant increase in basal serum TSH, whereas the corresponding humans did not (Table 3 ). In general, mice have a more robust response than humans to changes of serum TH of similar magnitude. This is also manifested by the higher proportional elevation of serum TSH in mice with RTH-b than in humans despite a similar relative difference in TH levels (Table 1) . Because metabolism of TH in the anterior pituitary cannot account for changes in serum TH concentrations, the observed differences in rT 3 /T 3 ratios suggest that exposure to high TH during intrauterine life may alter the metabolism of TH in other tissues. However, subtle differences in endogenous concentrations of TH were excluded due to the observed reduced sensitivity to TH by the administration of L-T 3 , which greatly increased, and, to the same degree, due to the serum T 3 concentration in the two groups of humans (Table 2) .
In summary, our data show that intrauterine exposure to increased TH concentrations has permanent consequences on the progeny. Increased inactivation of TH in the anterior pituitary may be protective in utero, but this effect persists into adulthood. This is likely due to an effect mediated through an increased expression of D3. Whether this apparent epigenetic effect is transmitted to the following generation is under investigation.
